Jump Financial, LLC Recursion Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$6.59 - $15.86 $1.59 Million - $3.83 Million	241,615 Added 2039.12%	253,464 $1.94 Million
Q3 2023 Nov 07, 2023	BUY	$6.59 - $15.86 $1.59 Million - $3.83 Million	241,615 Added 2039.12%	253,464 $1.94 Million
Q2 2023 Oct 21, 2024	SELL	$4.56 - $9.94 $536,675 - $1.17 Million	-117,692 Reduced 90.85%	11,849 $88,000
Q2 2023 Aug 07, 2023	SELL	$4.56 - $9.94 $536,675 - $1.17 Million	-117,692 Reduced 90.85%	11,849 $88,000
Q1 2023 Oct 21, 2024	BUY	$6.42 - $9.64 $831,653 - $1.25 Million	129,541 New	129,541 $864,000
Q1 2023 May 03, 2023	BUY	$6.42 - $9.64 $831,653 - $1.25 Million	129,541 New	129,541 $864,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.